Get started
Author

Marco Mazzotta

Observed name: M. Mazzotta
ORCID: 0009-0002-2620-643X
Observed ORCIDs: 0009-0002-2620-643X, 0000-0002-5478-9831
OpenAlex ID: A5103080595
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma
2022 · S. Scalera, B. Ricciuti, et al. · Annals of Oncology · 42
PDF
Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al. · Clinical Cancer Research · 7
PDF
KEAP1 and TP53 Mutations in Lung Cancer: More Is Better. Reply to: “Survival Analysis of TP53 Co-Mutations Should Be Interpreted More Cautiously”
2022 · Stefano Scalera, Marco Mazzotta, et al. · Journal of Thoracic Oncology · 4
Intratumoral Immune Heterogeneity Drives Divergent Outcomes to PD-(L)1 Blockade in Lung Cancer
2026 · Laura Cipriani, Davide Mascolo, et al. · Clinical Cancer Research · 1
Prognostic value of lymph node ratio (LNR) and log odds of positive lymph nodes (LODDS) in patients with locally advanced triple-negative breast cancer: An oncological-high flow center experience
2025 · Ilaria Puccica, Sonia Cappelli, et al. · Il Giornale di Chirurgia - Journal of the Italian Association of Hospital Surgeons
Supplementary Figure S22 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Figure S9 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Figure S4 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Figure S14 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Figure S10 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Table S3 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Figure S18 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Table S4 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Data from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Figure S19 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Table S1 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Figure S15 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Table S2 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Figure S21 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Figure S23 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Figure S7 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Figure S17 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Figure S11 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Figure S20 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Supplementary Figure S3 from Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy
2024 · Stefano Scalera, Biagio Ricciuti, et al.
Works count: 35
Citation count: 54
H-index: 3
I10-index: 1
Year
Topic
Type